About Anushka Mukherjee
Anushka's fascination with the stock market and its intricacies began during her time as an equity research intern after graduating with a bachelor's degree in commerce.
To kickstart her professional journey, she embarked on the role of an Investment Analyst while concurrently pursuing the CFA program.
Anushka's ultimate aim is to equip investors with essential knowledge that empowers them to make well-informed investment choices and attain sustained financial prosperity in the long run.
Recent Articles By Anushka Mukherjee
Making Sense of Oracle's (ORCL) Earnings and What It Means for Investors
In light of the recently revealed fiscal second-quarter results by the leading software giant Oracle Corp (ORCL) and the optimistic outlook for the software industry, driven by robust demand for cloud-based solutions, should investors consider adding the stock to their portfolio? Let’s find out…
Analyzing the Holiday Gain Potential of 3 Travel Stocks
The travel industry seems poised for growth as the holiday season unfolds. In light of this, which travel stock among Ryanair Holdings (RYAAY), Atour Lifestyle Holdings (ATAT), and Norwegian Cruise Line Holdings (NCLH) is well-equipped to capitalize on the industry prospects? Let’s find out…
Etsy (ETSY) vs. Meta (META) - Picking the Leading Internet Stock for December
Amid surging internet activity and heightened demand for internet services, the internet industry’s prospects appear enticing. In this favorable scenario, which internet stock among Etsy, Inc. (ETSY) and Meta Platforms, Inc. (META) holds greater potential to thrive? Let’s find out…
Year-End Insights for 3 Top Rated Agriculture Stocks
As 2023 comes to an end, the agricultural industry is anticipated to stay afloat on the backs of extensive technology integration and unwavering government support. In light of this, three top-notch agricultural stocks, AGCO Corp (AGCO), ICL Group (ICL), and Adecoagro S.A. (AGRO), might be solid year-end investments. Read more…
3 Pharma Powerhouses to Boost Your Year-End Investments
Backed by an ever-growing need for chronic disease treatments, rapid investments in research and development, and widespread integration of technology, the pharmaceutical sector is anticipated to flourish. Thus, as we approach the end of 2023, three solid pharma stocks, GoodRx Holdings (GDRX), CytomX Therapeutics (CTMX), and Neurocrine Biosciences (NBIX), could be ideal portfolio additions. Read more…
Adobe (ADBE) Pre-Earnings Insights
After a stellar fiscal third quarter performance and a solid year-to-date rally in its share price, Adobe Inc. (ADBE) is all set to unveil its fiscal fourth quarter results. As the software giant continues to harness the capabilities of AI across its product suite, could it be wise to adopt a bullish outlook on the stock? Keep reading to find out…
Nucor (NUE) vs. Steel Dynamics (STLD) - Predicting the Better Steel Stock
As industrialization and manufacturing continue to expand globally, there is a sustained increase in the demand for steel products. Therefore, which stock among Nucor Corp (NUE) and Steel Dynamics (STLD) is better equipped to capitalize on the industry prospects? Let’s find out…
Bearish or Bullish: Deciphering the 3 Best China Stocks for December
China, the world’s second-largest economy, exhibited resilience even in the face of several macroeconomic challenges. In this context, should investors invest in the shares of Chinese stocks: Alibaba Group (BABA), Weibo Corp (WB), and Autohome Inc. (ATHM)? Read on…
Pfizer Inc. (PFE) vs. Taro Pharmaceutical (TARO) - Betting on Which Pharma Stock Will Have Q4 Dominance
The pharmaceutical industry’s prospects are driven by the rising occurrence of chronic diseases coupled with the adoption of cutting-edge technology. In this context, which company among the two major industry players, Pfizer Inc. (PFE) and Taro Pharmaceutical (TARO) are going to dominate the fourth quarter? Let’s find out…